Ndaba Mazibuko

1.2k total citations · 1 hit paper
23 papers, 702 citations indexed

About

Ndaba Mazibuko is a scholar working on Cognitive Neuroscience, Experimental and Cognitive Psychology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Ndaba Mazibuko has authored 23 papers receiving a total of 702 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cognitive Neuroscience, 5 papers in Experimental and Cognitive Psychology and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Ndaba Mazibuko's work include Stress Responses and Cortisol (4 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (3 papers) and Advanced MRI Techniques and Applications (3 papers). Ndaba Mazibuko is often cited by papers focused on Stress Responses and Cortisol (4 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (3 papers) and Advanced MRI Techniques and Applications (3 papers). Ndaba Mazibuko collaborates with scholars based in United Kingdom, United States and Germany. Ndaba Mazibuko's co-authors include Mitul A. Mehta, Steven Williams, Fiona Patrick, William Trender, Samuel R. Chamberlain, Jon E. Grant, Joseph M Barnby, Peter J. Hellyer, Amy Jolly and Adam Hampshire and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Scientific Reports.

In The Last Decade

Ndaba Mazibuko

20 papers receiving 682 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cognitive deficits in people who have recovered from COVID-19

2021 400 citations Adam Hampshire, William Trender et al. EClinicalMedicine profile →

Peers

Countries citing papers authored by Ndaba Mazibuko

Since Specialization

Citations

This map shows the geographic impact of Ndaba Mazibuko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ndaba Mazibuko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ndaba Mazibuko more than expected).

Fields of papers citing papers by Ndaba Mazibuko

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ndaba Mazibuko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ndaba Mazibuko. The network helps show where Ndaba Mazibuko may publish in the future.

Co-authorship network of co-authors of Ndaba Mazibuko

This figure shows the co-authorship network connecting the top 25 collaborators of Ndaba Mazibuko. A scholar is included among the top collaborators of Ndaba Mazibuko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ndaba Mazibuko. Ndaba Mazibuko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The GPR139 agonist TAK-041 produces time-dependent alterations to cerebral blood flow and reward system function in patients with schizophrenia: a randomised placebo-controlled trial 2025 ·Psychopharmacology ·Peter C.T. Hawkins, Adam J. Schwarz, James Stone, Fiona Pepper, James Gilleen, (unknown), Ndaba Mazibuko, Dimitrios Arkilo, Wei Yin, (unknown), Polyna Khudyakov, (unknown), Laura Rosen, Joel A. Posener, Mitul A. Mehta, Antonio Laurenza	0
2	Novel Lipid Formulation Increases Absorption of Oral Cannabidiol (CBD) 2024 ·Pharmaceutics ·Edward Chesney, Ndaba Mazibuko, Dominic Oliver, Amedeo Minichino, (unknown), (unknown), Thomas J. Reilly, (unknown), Matilda Kråkström, Alex M. Dickens, Matej Orešič, Eric M. Lynch, Gregory Stoloff, Mitul A. Mehta, Philip McGuire	1
3	Visual mismatch negativity in Parkinson's psychosis and potential for testing treatment mechanisms 2024 ·Brain Communications ·(unknown), Dominic ffytche, Ndaba Mazibuko, (unknown), Marcella Montagnese, (unknown), David Nutt, Anthony S. Gabay, Yen Tai, Lucia Batzu, Valentina Leta, C. H. Gray, К. Ray Chaudhuri, Mitul A. Mehta	2
4	Acute effects of mifepristone on emotional processing related brain activity: A functional MRI study 2023 ·European Neuropsychopharmacology ·Nefize Yalın, Matthew J. Kempton, Ndaba Mazibuko, Mitul A. Mehta, Allan H. Young, Paul Stokes	0
5	The effects of acute Methylene Blue administration on cerebral blood flow and metabolism in humans and rats 2023 ·Journal of Cerebral Blood Flow & Metabolism ·Nisha Singh, Eilidh MacNicol, Ottavia Dipasquale, Karen Randall, David J. Lythgoe, Ndaba Mazibuko, Camilla Simmons, Pierluigi Selvaggi, (unknown), Federico Turkheimer, Diana Cash, Fernando Zelaya, Alessandro Colasanti	5
6	Comparison of Cerebral Blood Flow in Regions Relevant to Cognition After Enzalutamide, Darolutamide, and Placebo in Healthy Volunteers: A Randomized Crossover Trial 2023 ·Targeted Oncology ·Steven Williams, Ndaba Mazibuko, Owen O’Daly, Christian Zurth, Fiona Patrick, Christian Kappeler, Iris Kuss, Patricia E. Cole	9
7	“Less is more”: A dose-response account of intranasal oxytocin pharmacodynamics in the human brain 2022 ·Progress in Neurobiology ·Daniel Martins, (unknown), Mattia Veronese, Ottavia Dipasquale, Ndaba Mazibuko, Uwe Schuschnig, Fernando Zelaya, Aikaterini Fotopoulou, Yannis Paloyelis	23
8	Mapping the effects of atomoxetine during response inhibition across cortical territories and the locus coeruleus 2021 ·Psychopharmacology ·Rong Ye, Ndaba Mazibuko, Jens Teichert, Ralf Regenthal, Angie A. Kehagia, Mitul A. Mehta	2
9	Cognitive deficits in people who have recovered from COVID-19 breakdown → 2021 ·EClinicalMedicine ·Adam Hampshire, William Trender, Samuel R. Chamberlain, Amy Jolly, Jon E. Grant, Fiona Patrick, Ndaba Mazibuko, Steven Williams, Joseph M Barnby, Peter J. Hellyer, Mitul A. Mehta	400
10	Ketamine Modulates the Neural Correlates of Reward Processing in Unmedicated Patients in Remission From Depression 2021 ·Biological Psychiatry Cognitive Neuroscience and Neuroimaging ·(unknown), Argyris Stringaris, Nuria Mackes, Ndaba Mazibuko, Peter C.T. Hawkins, Maura Furey, H. Valerie Curran, Mitul A. Mehta	11
11	Ketamine effect on inflammation: A double-blind placebo-controlled randomised study 2021 ·Brain Behavior and Immunity ·Naghmeh Nikkheslat, (unknown), Ndaba Mazibuko, Valeria Mondelli, Mitul A. Mehta, Carmine M. Pariante	0
12	Cholinergic modulation of disorder-relevant human defensive behaviour in generalised anxiety disorder 2021 ·Translational Psychiatry ·Adam M. Perkins, Fiona Patrick, Toby Wise, Nicholas Meyer, Ndaba Mazibuko, (unknown), (unknown), Philippe Danjou, Susan O’Connor, (unknown), Caroline Wooldridge, (unknown), Christine Macare, Steven Williams, Allan H. Young	11
13	Effects of route of administration on oxytocin-induced changes in regional cerebral blood flow in humans 2020 ·Nature Communications ·Daniel Martins, Ndaba Mazibuko, Fernando Zelaya, (unknown), (unknown), (unknown), Stefanos Maltezos, Mitul A. Mehta, Stephen Wastling, Matthew A. Howard, Gráinne McAlonan, Declan Murphy, Steven Williams, Aikaterini Fotopoulou, Uwe Schuschnig, Yannis Paloyelis	101
14	Cholinergic Modulation of Disorder-Relevant Neural Circuits in Generalized Anxiety Disorder 2020 ·Biological Psychiatry ·Toby Wise, Fiona Patrick, Nicholas Meyer, Ndaba Mazibuko, (unknown), (unknown), Philippe Danjou, Susan O’Connor, (unknown), Caroline Wooldridge, (unknown), Christine Macare, Steven Williams, Adam M. Perkins, Allan H. Young	26
15	Mifepristone enhances the neural efficiency of human visuospatial memory encoding and recall 2020 ·Psychoneuroendocrinology ·Nefize Yalın, Matthew J. Kempton, Ndaba Mazibuko, Mitul A. Mehta, Allan H. Young, Paul Stokes	3
16	Patterns of Mitochondrial TSPO Binding in Cerebral Small Vessel Disease: An in vivo PET Study With Neuropathological Comparison 2020 ·Frontiers in Neurology ·Paul Wright, Mattia Veronese, Ndaba Mazibuko, Federico Turkheimer, Eugenii A. Rabiner, Clive Ballard, Steven Williams, (unknown), (unknown), (unknown), Tiago Reis Marques, Oliver Howes, Federico Roncaroli, Michael O’Sullivan	11
17	Significant localized reduction in cerebral blood flow (CBF) in regions relevant to cognitive function with enzalutamide (ENZA) compared to darolutamide (DARO) and placebo (PBO) in healthy volunteers. 2020 ·Journal of Clinical Oncology ·Steven Williams, Ndaba Mazibuko, Owen O’Daly, Christian Zurth, Fiona Patrick, Caroline Wooldridge, (unknown), Iris Kuss, Patricia L. Cole	11
18	Subacute Changes in N-Acetylaspartate (NAA) Following Ischemic Stroke: A Serial MR Spectroscopy Pilot Study 2020 ·Diagnostics ·Ndaba Mazibuko, Ruth Tuura, L. Sztriha, Owen O’Daly, Gareth J. Barker, Steven Williams, Michael O’Sullivan, Lalit Kalra	14
19	A New Method for Ethical and Efficient Evidence Generation for Off-Label Medication Use in Oncology (A Case Study in Glioblastoma) 2019 ·Frontiers in Pharmacology ·Samir Agrawal, (unknown), Ndaba Mazibuko, (unknown), (unknown), Shanna Wilson, Sarah Edwards	13
20	An investigation of regional cerebral blood flow and tissue structure changes after acute administration of antipsychotics in healthy male volunteers 2017 ·Human Brain Mapping ·Peter C.T. Hawkins, Tobias Wood, Anthony C. Vernon, Alessandro Bertolino, Fabio Sambataro, Juergen Dukart, Emilio Merlo‐Pich, Céline Risterucci, (unknown), Eamonn Walsh, Ndaba Mazibuko, Fernando Zelaya, Mitul A. Mehta	25

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact